| Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy J Garcia-Aguilar, S Patil, MJ Gollub, JK Kim, JB Yuval, HM Thompson, ... Journal of Clinical Oncology 40 (23), 2546-2556, 2022 | 610 | 2022 |
| Adoption of total neoadjuvant therapy for locally advanced rectal cancer A Cercek, CSD Roxburgh, P Strombom, JJ Smith, LKF Temple, GM Nash, ... JAMA oncology 4 (6), e180071-e180071, 2018 | 578 | 2018 |
| Assessment of a watch-and-wait strategy for rectal cancer in patients with a complete response after neoadjuvant therapy JJ Smith, P Strombom, OS Chow, CS Roxburgh, P Lynn, A Eaton, ... JAMA oncology 5 (4), e185896-e185896, 2019 | 522 | 2019 |
| Management of brain metastases in tyrosine kinase inhibitor–naïve epidermal growth factor receptor–mutant non–small-cell lung cancer: a retrospective multi-institutional analysis WJ Magnuson, NH Lester-Coll, AJ Wu, TJ Yang, NA Lockney, NK Gerber, ... Journal of clinical oncology 35 (10), 1070-1077, 2017 | 485 | 2017 |
| Comparison of tumor regression grade systems for locally advanced rectal cancer after multimodality treatment A Trakarnsanga, M Gönen, J Shia, GM Nash, LK Temple, JG Guillem, ... Journal of the National Cancer Institute 106 (10), dju248, 2014 | 259 | 2014 |
| Neoadjuvant chemotherapy first, followed by chemoradiation and then surgery, in the management of locally advanced rectal cancer A Cercek, KA Goodman, C Hajj, E Weisberger, NH Segal, ... Journal of the National Comprehensive Cancer Network 12 (4), 513-519, 2014 | 254 | 2014 |
| Phase II study of hemithoracic intensity-modulated pleural radiation therapy (IMPRINT) as part of lung-sparing multimodality therapy in patients with malignant pleural mesothelioma A Rimner, MG Zauderer, DR Gomez, PS Adusumilli, PK Parhar, AJ Wu, ... Journal of Clinical Oncology 34 (23), 2761-2768, 2016 | 196 | 2016 |
| Radiation therapy for small cell lung cancer: an ASTRO clinical practice guideline CB Simone II, JA Bogart, AR Cabrera, ME Daly, NJ DeNunzio, ... Practical radiation oncology 10 (3), 158-173, 2020 | 180 | 2020 |
| Fatal complications after stereotactic body radiation therapy for central lung tumors abutting the proximal bronchial tree JM Haseltine, A Rimner, DY Gelblum, A Modh, KE Rosenzweig, ... Practical radiation oncology 6 (2), e27-e33, 2016 | 176 | 2016 |
| Association of ablative radiation therapy with survival among patients with inoperable pancreatic cancer M Reyngold, EM O’Reilly, AM Varghese, M Fiasconaro, M Zinovoy, ... JAMA oncology 7 (5), 735-738, 2021 | 159 | 2021 |
| Expert consensus contouring guidelines for intensity modulated radiation therapy in esophageal and gastroesophageal junction cancer AJ Wu, WR Bosch, DT Chang, TS Hong, SK Jabbour, LR Kleinberg, ... International Journal of Radiation Oncology* Biology* Physics 92 (4), 911-920, 2015 | 157 | 2015 |
| Intensity-modulated radiotherapy in postoperative treatment of oral cavity cancers DR Gomez, JE Zhung, J Gomez, K Chan, AJ Wu, SL Wolden, DG Pfister, ... International Journal of Radiation Oncology* Biology* Physics 73 (4), 1096-1103, 2009 | 148 | 2009 |
| Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative … CJ Tsai, JT Yang, N Shaverdian, J Patel, AF Shepherd, J Eng, ... The Lancet 403 (10422), 171-182, 2024 | 117 | 2024 |
| Local control and toxicity in a large cohort of central lung tumors treated with stereotactic body radiation therapy A Modh, A Rimner, E Williams, A Foster, M Shah, W Shi, Z Zhang, ... International Journal of Radiation Oncology* Biology* Physics 90 (5), 1168-1176, 2014 | 117 | 2014 |
| Erlotinib versus radiation therapy for brain metastases in patients with EGFR-mutant lung adenocarcinoma NK Gerber, Y Yamada, A Rimner, W Shi, GJ Riely, K Beal, AY Helena, ... International Journal of Radiation Oncology* Biology* Physics 89 (2), 322-329, 2014 | 117 | 2014 |
| Long-term results of organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy: the randomized phase II OPRA trial FS Verheij, DM Omer, H Williams, ST Lin, LX Qin, JT Buckley, ... Journal of Clinical Oncology 42 (5), 500-506, 2024 | 116 | 2024 |
| Unresectable carcinoma of the paranasal sinuses: outcomes and toxicities BS Hoppe, CJ Nelson, DR Gomez, LD Stegman, AJ Wu, SL Wolden, ... International Journal of Radiation Oncology* Biology* Physics 72 (3), 763-769, 2008 | 106 | 2008 |
| Toxicity and outcomes of thoracic re-irradiation using stereotactic body radiation therapy (SBRT) M Reyngold, AJ Wu, A McLane, Z Zhang, M Hsu, NF Stein, Y Zhou, AY Ho, ... Radiation oncology 8, 1-7, 2013 | 93 | 2013 |
| Safety and feasibility of esophagectomy following combined immunotherapy and chemoradiotherapy for esophageal cancer S Sihag, GY Ku, KS Tan, S Nussenzweig, A Wu, YY Janjigian, DR Jones, ... The Journal of thoracic and cardiovascular surgery 161 (3), 836-843. e1, 2021 | 89 | 2021 |
| Recurrence patterns and second primary lung cancers after stereotactic body radiation therapy for early-stage non–small-cell lung cancer: implications for surveillance DE Spratt, AJ Wu, V Adeseye, SU Din, F Shaikh, KM Woo, Z Zhang, ... Clinical lung cancer 17 (3), 177-183. e2, 2016 | 82 | 2016 |
